Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fructus Tribuli is the dried fruit of the plant *Tribulus terrestris* L., widely used in traditional Chinese medicine (TCM) and Ayurveda. It contains a variety of bioactive constituents, including steroidal saponins (such as protodioscin), flavonoids (kaempferol, quercetin, luteolin), and alkaloids. The drug is primarily investigated for its potential in treating male reproductive disorders, such as oligospermia and erectile dysfunction, by potentially modulating androgen levels or nitric oxide signaling. Additionally, research in animal models suggests that Fructus Tribuli may possess neuroprotective, anxiolytic, and antidepressant properties, possibly mediated through the inhibition of monoamine oxidase A (MAO-A) and antioxidant effects. Clinical trials have explored its efficacy and safety in improving sperm parameters in men with oligospermia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fructus tribuli.